HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: 2452061726v1 245/3/692    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yang, W. T. Articles by Macapinlac, H. A. Search for Related Content PubMed PubMed Citation Articles by Yang, W. T. Articles by Macapinlac, H. A.

Breast Lymphoma: Imaging Findings of 32 Tumors in 27 Patients¹

¹ From the Departments of Diagnostic Radiology (W.T.Y., D.L.L., H.T.L.), Pathology (L.V.A.), and Nuclear Medicine (H.A.M.), the University of Texas, M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1350, Houston, TX 77030. Received October 5, 2006; revision requested December 7; revision received January 9, 2007; accepted January 29; final version accepted March 27. Address correspondence to W.T.Y. (e-mail: wyang{at}di.mdacc.tmc.edu).

Purpose: To retrospectively evaluate the imaging findings of breast lymphomas in patients who had undergone mammography, ultrasonography (US), magnetic resonance (MR) imaging, or combined positron emission tomography (PET)/computed tomography (CT) scanning.

Materials and Methods: The institutional review board approved this HIPAA-compliant study and waived informed consent. Twenty-seven women who had been diagnosed with breast lymphoma (32 tumors) and had undergone preoperative imaging were identified from the surgical pathology database (mean age, 51 years; median, 55 years; range, 19–78 years at time of diagnosis). Two radiologists reviewed the mammographic, US, and MR images. One nuclear medicine physician reviewed the PET/CT scans. All available pathologic specimens were reviewed by a hematologic pathologist.

Results: The mean tumor size at diagnosis was 2.9 cm (range, 1–5 cm). Seventeen tumors manifested with a palpable mass, two with diffuse enlargement of the breast, and 13 were asymptomatic. Twenty-two women underwent mammography; 24, US; one, MR imaging; and 10, PET/CT scanning. Mammograms of 25 tumors showed a noncalcified mass in 19, global asymmetry in four, focal asymmetry in one, and no abnormality in one. US of 29 tumors showed a mass in 26 and diffuse architectural distortion in three. Masses typically were irregular, hypoechoic, and hypervascular and demonstrated indistinct margins or an echogenic boundary. Dynamic contrast material–enhanced MR imaging of one tumor showed an intensely and heterogeneously enhancing mass with rapid enhancement and washout characteristics. PET/CT scans of 13 tumors showed intense diffuse hypermetabolism in 12 and response to therapy in all 12 tumors.

Conclusion: The imaging findings reported in this study should alert the radiologist to a possible diagnosis of breast lymphoma.

© RSNA, 2007

This article has been cited by other articles:

				G. Martinelli, G. Ryan, J. F. Seymour, L. Nassi, S. Steffanoni, A. Alietti, L. Calabrese, G. Pruneri, L. Santoro, M. Kuper-Hommel, et al. Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group Ann. Onc., July 1, 2009; (2009) mdp238v1. [Abstract] [Full Text] [PDF]

				L. Preda, S. Rizzo, M. Bellomi, W. Tse Yang, and H. T. Le-Petross MR Imaging of Breast Lymphoma Radiology, July 1, 2008; 248(1): 320 - 321. [Full Text] [PDF]